Dr Lal PathLabs Q2 FY27 Consolidated Results
Dr. Lal PathLabs Ltd 路 Press Release 路 04 Nov 2026, 7:45 pm
Dr Lal PathLabs Q2 FY27 Consolidated Results Dr Lal PathLabs reported strong Q2 FY27 financial results, with consolidated revenue rising 19.6% YoY to Rs 874 Cr. EBITDA increased 25.1% YoY to Rs 280 Cr, expanding margins by 140 bps to 32.1%. PAT grew 27.5% YoY to Rs 194 Cr with a 22.2% margin, while EPS stood at Rs 11.5. The company declared an interim dividend of 50% (Rs 5 per share). Cash and cash equivalents reached Rs 1,746 Cr as of 30th Sep'26.
Original exchange filing (PDF)
More announcements from Dr. Lal PathLabs Ltd
- Attached 路 11 Nov 2026
- Attached 路 10 Nov 2026
- Attached 路 05 Nov 2026
- Attached 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates 路 04 Nov 2026
